Casino, Guichard-Perrachon SA : Hesitation should subside in favor of volatility
BUY
Conditionne
Target price hit
Entry price | Target | Stop-loss | Potential |
---|
€47.25 |
€50.2 |
€46.25 |
+6.24% |
---|
The price of Casino Guichard shares is range-bound. This phase will end sooner or later when volatility comes back.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● The company shows low valuation levels, with an enterprise value at 0.2 times its sales.
● This company will be of major interest to investors in search of a high dividend stock.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses● The stock is close to a major daily resistance at EUR 47.02, which should be gotten rid of so as to gain new appreciation potential.
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company does not generate enough profits, which is an alarming weak point.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.